ChemicalBook > CAS DataBase List > Blosozumab

Blosozumab

Product Name
Blosozumab
CAS No.
1132758-87-2
Chemical Name
Blosozumab
Synonyms
Blosozumab;Blosozumab (anti-SOST);Research Grade Blosozumab;Research Grade Blosozumab(DHJ48702)
CBNumber
CB08080837
Formula Weight
0
MOL File
Mol file
More
Less

Blosozumab Property

form 
Liquid
color 
Colorless to light yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Biosynth
Product number
CLA1277
Product name
Blosozumab
Packaging
1mg
Price
$618.75
Updated
2026/06/04
Biosynth
Product number
CLA1277
Product name
Blosozumab
Packaging
10mg
Price
$2062.5
Updated
2026/06/04
Biosynth
Product number
CLA1277
Product name
Blosozumab
Packaging
100mg
Price
$8250
Updated
2026/06/04
ChemScene
Product number
CS-0612896
Product name
Blosozumab
Purity
99.45%
Packaging
1mg
Price
$379
Updated
2026/06/04
ChemScene
Product number
CS-0612896
Product name
Blosozumab
Purity
99.45%
Packaging
5mg
Price
$1029
Updated
2026/06/04
More
Less

Blosozumab Chemical Properties,Usage,Production

Uses

Blosozumab (LY2541546) is an anti-Human sclerostin (SOST) antibody inhibitor. Blosozumab stimulates bone formation and reduces bone resorption. Blosozumab can be used in the research of Osteoporosis[1][2].

in vivo

Blosozumab (1-100 mg/kg, i.v.) shows effects of hyperostosis in rats[1].

Animal Model:Sprague-Dawley rats [2]
Dosage:1, 10, and 100 mg/kg
Administration:Intravenous injection (i.v.), once every 3 days (5-week study) or once weekly (6-month study)
Result:Observed the bone anabolic effects.
Showed significant bleeding and morbidity at 100 mg/kg.
Decreases in the numbers of platelets.
Increased number of bone marrow megakaryocytes at 100 mg/kg.

References

[1] Robert R Recker, et al. A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density. J Bone Miner Res. 2015 Feb;30(2):216-24. DOI:10.1002/jbmr.2351
[2] Daniel G Rudmann, et al. Rat-specific decreases in platelet count caused by a humanized monoclonal antibody against sclerostin. Toxicol Sci. 2012 Feb;125(2):586-94. DOI:10.1093/toxsci/kfr318

Blosozumab Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Blosozumab Suppliers

Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Fax
QQ:3008007432
Email
3008007409@qq.com
Country
China
ProdList
89686
Advantage
60
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8000
Advantage
62
BOC Sciences
Tel
16314854226; +16314854226
Email
inquiry@bocsci.com
Country
United States
ProdList
19853
Advantage
58
Guangzhou Hongyuan Chemical Co.,Ltd
Tel
15817493340
Email
981810490@qq.com
Country
China
ProdList
1566
Advantage
58
Wuhan Chemstan Biotechnology Co., Ltd.
Tel
027-65317797 15926423062
Fax
QQ:422450190
Email
422450190@qq.com
Country
China
ProdList
10308
Advantage
58
TargetMol Chemicals Inc.
Tel
4008200310 15002144251
Email
marketing@tsbiochem.com
Country
China
ProdList
24955
Advantage
58
Biolab Reagents
Tel
027-65279366 18108604356
Email
products@biolabreagent.com
Country
China
ProdList
9865
Advantage
58
Wuhan Jingkangen Biomedical Technology Co., Ltd
Tel
13720134139 086-15871494362 13720134139
Email
orders@jknbiochem.com
Country
China
ProdList
7086
Advantage
58
Shanghai Yifei Biotechnology Co. , Ltd.
Tel
021-65675885 18964387627
Email
customer_service@efebio.com
Country
China
ProdList
11972
Advantage
58
Wuhan Acumen Bio-Technology Co.,ltd
Tel
027-027-16602739303 16602739303
Email
673003916@qq.com
Country
China
ProdList
4591
Advantage
58

1132758-87-2, BlosozumabRelated Search:


  • Blosozumab
  • Research Grade Blosozumab(DHJ48702)
  • Blosozumab (anti-SOST)
  • Research Grade Blosozumab
  • 1132758-87-2